New antibody combo shows promise for Tough-to-Treat blood cancers
NCT ID NCT04623541
First seen Jun 26, 2026 · Last updated Aug 05, 2026 · Updated 5 times
Summary
This study tests an experimental antibody called epcoritamab, which helps the immune system target and kill cancer cells. It is being tested alone or with other drugs in about 194 people with relapsed/refractory chronic lymphocytic leukemia (CLL) or Richter's syndrome. The goal is to see if it is safe and effective, with treatment lasting up to 2 years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Epcoritamab (an antibody that helps the immune system attack cancer cells), given alone or with other drugs like venetoclax, pirtobrutinib, lenalidomide, or R-CHOP chemotherapy.
- What this could lead to
- If successful, this could provide a new treatment option for people with hard-to-treat CLL or Richter's syndrome, potentially improving response rates and extending survival.
- What could go wrong
- This is an early-phase trial (1b/2), so safety and effectiveness are not yet proven. Side effects like cytokine release syndrome or nerve problems are possible, and the treatment may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AOC Arcispedale Saint'Anna
Coaña, Ferarra, Spain
-
AOU Arcispedale Sant'Anna
Ferrara, Cona, 44124, Italy
-
AOU Città della Salute e della Scienza di Torino
Torino, 10126, Italy
-
AOU Policlinico Sant'Orsola Malpighi IRCCS
Bologna, 00161, Italy
-
AOU Policlinico Umberto I
Roma, 00161, Italy
-
AZ Sint-Jan
Bruges, 8000, Belgium
-
Aalborg University Hospital
Aalborg, 9100, Denmark
-
Aidport sp z o.o.
Skorzewo, Poland
-
Albert Schweitzer Ziekenhuis, Dordwijk
Dordrecht, South Holland, 3318 AT, Netherlands
-
Alfred Health
Melbourne, Victoria, 3004, Australia
-
Amsterdam UMC
Amsterdam, 1105 AZ, Netherlands
-
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili)
Brescia, Italy
-
Barwon Health
Geelong, Victoria, Australia
-
Bnai Zion Medical Center
Haifa, Israel
-
CHU Clermont Ferrand
Clermont-Ferrand, Puy De Dome, 63000, France
-
CHU Hôpital Haut-Lévêque Bordeaux
Pessac, Gironde, 33404, France
-
CHU Hôpital de Brabois Nancy
Vandœuvre-lès-Nancy, Meurthe Et Moselle, 54500, France
-
CHU de Montpellier Hôpital Saint Eloi
Montpellier, Cedex 5, 34090, France
-
Cedars-Sinai Medical Center
Los Angeles, California, 90048, United States
-
Chaim Sheba Medical Center
Ramat Gan, Israel
-
City of Hope National Medical Center
Duarte, California, 91010, United States
-
Columbia University Herbert Irving Comprehensive Cancer Center
New York, New York, 10032, United States
-
David Geffen School of Medicine
Los Angeles, California, 90095, United States
-
Duke University Medical Center
Durham, North Carolina, 27708, United States
-
Fakultni Nemocnice Ostrava
Ostrava, Poruba, Czechia
-
Fakultni nemocnice Brno
Brno, 625 00, Czechia
-
Fakultni nemocnice Hradec Kralove
Hradec Králové, Nový Hradec Králové, 500 05, Czechia
-
Fakultni nemocnice Olomouc
Olomouc, 779 00, Czechia
-
Flinders Medical Centre
Bedford Park, South Australia, 5042, Australia
-
Fred Hutchinson Cancer Research Center
Seattle, Washington, 98109, United States
-
Hackensack Meridian Hospital
Hackensack, New Jersey, 07601, United States
-
Hadassah University Hospital - Ein Kerem
Jerusalem, Israel
-
Henry Ford Medical Group
Detroit, Michigan, 48202, United States
-
Hospital Clinic de Barcelona
Barcelona, 08036, Spain
-
Hospital Clinico Universitario de Valencia
Valencia, València, 46010, Spain
-
Hospital Universitario Fundacion Jiménez Díaz
Madrid, 28040, Spain
-
Hospital Universitario Ramón y Cajal
Madrid, 28034, Spain
-
Hospital Universitario Virgen Macarena
Seville, Spain
-
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
-
Hôpital Privé du Confluent
Nantes, Pays de la Loire Region, 44000, France
-
Hôpital Saint-Louis
Paris, 75010, France
-
Hôpital Universitaire Pitié-Salpêtrière
Paris, 75013, France
-
IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST
Meldola, Forli - Cesena, 47014, Italy
-
IRCCS Policlinico Universitario Agostino Gemelli
Rome, Lazio, 00136, Italy
-
Istituto di Candiolo
Torino, Candiolo, 10060, Italy
-
Maastricht University Medical Center
Maastricht, Limburg, 6229 HX, Netherlands
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Memorial Healthcare System
Pembroke Pines, Florida, 33024, United States
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
Mount Sinai Comprehensive Cancer Center
Miami Beach, Florida, 33140, United States
-
National Institutes of Health
Bethesda, Maryland, 20892, United States
-
Northwell Health Cancer Institute
Lake Success, New York, 11043, United States
-
O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
-
Odense University Hospital
Odense, 5000, Denmark
-
Ospedale Maggiore di Novara
Novara, 28100, Italy
-
Ospedale San Raffaele
Milan, 20132, Italy
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, 3000, Australia
-
Pratia Malopolskie Medical Center Krakow (Pratia Małopolskie Centrum Medyczne Krakow)
Krakow, Poland
-
Pratia Medical Center Katowice (Centrum Medyczne Pratia Katowice)
Katowice, Poland
-
Rabin Medical Center-Beilinson Campus
Petah Tikva, 4941492, Israel
-
Rigshospitalet
Copenhagen, Capital Region, 2100, Denmark
-
Roskilde Sygehus
Roskilde, 4000, Denmark
-
St. George Hospital
Kogarah, New South Wales, Australia
-
Stanford Cancer Center
Palo Alto, California, 94305, United States
-
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
-
The Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
The University of Texas Southwestern Medical Centre
Dallas, Texas, 75390, United States
-
UZ Leuven
Leuven, 3000, Belgium
-
Universitaetsklinikum Koeln
Cologne, 50937, Germany
-
Universitaetsklinikum Schleswig-Holstein- Karl-Lennart-Krebscentrum
Kiel, 24105, Germany
-
Universitair Medisch Centrum Groningen
Groningen, 9713 GZ, Netherlands
-
Universitair Medisch Centrum Utrecht
Utrecht, 3584 CX, Netherlands
-
Universitair Ziekenhuis Gent
Ghent, 9000, Belgium
-
University of California Davis Medical Center Sacramento
California City, California, 95817, United States
-
University of Cincinnati
Cincinnati, Ohio, 45221, United States
-
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, 48190, United States
-
University of Pennsylvania School of medicine
Philadelphia, Pennsylvania, 19104, United States
-
Vejle Sygehus
Vejle, 7100, Denmark
-
Vseobecna Fakultni Nemocnice
Prague, Nové Město, 128 08, Czechia
-
Århus University Hospital
Aarhus, 8000, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill outsmart Treatment-Resistant blood cancer?
- Can a Three-Drug combo outsmart High-Risk CLL?
- Can a gentler dose of zanubrutinib keep CLL at bay in the very elderly?
- Can a Two-Drug combo wipe out hidden leukemia cells?
- New biologic MK-1045 targets Hard-to-Treat blood cancers
- New transplant recipe aims to tame Graft-Versus-Host disease